Economic evaluations of granulocyte colony-stimulating factor Marc EsserHelmut Brunner Review Article 23 December 2012 Pages: 1295 - 1313
The health economics of bladder cancer Marc F. BottemanChris L. PashosRobert Hauser Review Article 23 December 2012 Pages: 1315 - 1330
An evaluation of the cost effectiveness of drotrecogin alfa (activated) relative to the number of organ system failures Madeline BetancourtPeggy S. McKinnonJohn W. Devlin Original Research Article 23 December 2012 Pages: 1331 - 1340